0.88 USD
▼-0.01-0.87%
盘后 0.95 0.00%
2026-11-20
市值
$108.77M
市盈率
—
EPS
-0.24
股息率
—
52 周区间
0.86 – 2.34
成交量
106.02K
Beta
0.66
目标价
8.39
52W 低 0.8652W 高 2.34
价格走势

公司简介

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol fo...